Purchase by RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA Capital Nexus Fund IV, L.P. / Peter Kolchinsky / Rajeev M. Shah
2,840,429 shares · @ $18.39 · $52,222,946
Hemab Therapeutics Holdings, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $27.13
+12% in 7d after detection
Post-detection moves
1h
—
1d
+2.9%
3d
-0.0%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS